Healthy Growth across all verticals in FY'22 slide image

Healthy Growth across all verticals in FY'22

Our CRAM Partners Trusted Partners āœ“ Partnership with 50+ companies āœ“ Partnership expected with 3 more Indian MNC in FY'23 We value our CRAM partners Sustained growth Important clients FY 20-21 67% growth FY 21-22 Zydus CADILA INTAS dedicated elife PHARMACEUTICALS LIMITED The Care Continue RPG LIFE SCIENCES LIMITED ALKEM n torrent PHARMA BETA Brugs DRUGS LTD. Reliance CAPLIN POINT LABORATORIES LTD. BDR N AUREATE Shilpa Shilpa Medicare Ltd. HETERO HETERO Zuventus Panacea Biotec Healthcare Ltd. LIFE SCIENCES 1
View entire presentation